[Skip to Content]
View our RSS Feed
View our RSS Feed View our RSS Feed You are viewing the post list, filtered by category type. Select a post below for the full content.
Oct
07
0 comments
The NNLM’s Mid-Atlantic Region’s course on Health Statistics on the Web is being held on October 15th at 12 pm ET. This course focuses on the location, selection, and effective use of statistics relevant to health on the local, state, national, and international levels. The importance and relevance of health statistics in various contexts will… Read More »
Posted in: Announcements, Blog, Education and Outreach
Oct
02
0 comments
The National Library of Medicine invites the health services research community to provide comments on current information products and tools and help identify new types of information and resources that can best support the work of health services delivery and research. Comments are requested to assist NLM in assessing and planning to continue the work… Read More »
Posted in: Blog
Sep
30
0 comments
As of October 1, 2020, materials from HealthReach will be accessible exclusively via MedlinePlus, NLM’s flagship website for health information for patients, families, and the general public. The change to provide multilingual materials on MedlinePlus and end HealthReach as a stand-alone website is part of NLM’s plan to align and consolidate our consumer health information… Read More »
Posted in: Blog
Sep
01
0 comments
September is National Preparedness Month. Join us to learn about Grey Literature and how it can be helpful during evolving situations. NPHCO Education Coordinator Cecilia Vernes will teach Grey Literature Resources to Support Emergency Preparedness, Response and Recovery What is Grey Literature? How do you find it? And how can it help during emergency preparedness, response… Read More »
Posted in: Blog
Sep
01
0 comments
Scientists at Rocky Mountain Laboratories in Hamilton, Montana,conducted a preclinical study of the investigational vaccine AZD1222, their findings were recently published in Nature. AZD122 uses a viral vector to deliver a SARS-CoV-2 spike protein to induce immune response. See the full news release at Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate… Read More »
Posted in: Blog